Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150)

Korean Multiple Myeloma Working Party

Research output: Contribution to journalArticle

7 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150)'. Together they form a unique fingerprint.

Medicine & Life Sciences